Category Archives: Uncategorized

What They Said – FDA Press Releases in 2023

Less is more? Every so often is it worthwhile to look back at FDA to see what they had to say in a given year, and in addition, how they said it. One might not think that a large agency … Continue reading

Posted in Uncategorized | Tagged | Comments Off on What They Said – FDA Press Releases in 2023

Speaking of Medicine – Mid-Year OPDP Enforcement Review

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement … Continue reading

Posted in Uncategorized | Tagged , | Comments Off on Speaking of Medicine – Mid-Year OPDP Enforcement Review

New Approvals in 2022

We are at mid-year, a good time to check in and see how we are doing on a number of fronts – including where we are with new drug approvals. Over the years, Congress has acted to enhance the ability … Continue reading

Posted in Uncategorized | Comments Off on New Approvals in 2022

FDA Authorizes Third Dose – Some Implications

What does “fully vaccinated” mean today? In the face of the widening spread of the SARS-Cov-2 variant, the rise in breakthrough cases, and data that suggests a slight waning effect over time of vaccines, FDA acted yesterday to protect some … Continue reading

Posted in Uncategorized | Tagged , | Comments Off on FDA Authorizes Third Dose – Some Implications

Crisis Communications and FDA

In the face of a crisis situation, it is a given that the clarity and thoroughness of the communications response is key to resolving the issue and mitigating any reputational damage. Perhaps no other decision by the Food and Drug … Continue reading

Posted in Uncategorized | Tagged , , , | Comments Off on Crisis Communications and FDA